Theriva Biologics, Inc. Depreciation
Theriva Biologics, Inc. (TOVX) reported Depreciation of $111.00 thousand for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2016-11-01
- Theriva Biologics, Inc. depreciation for the quarter ending 2016-09-30 was $54.00K, a 170.00% increase year-over-year.
- Theriva Biologics, Inc. depreciation for the quarter ending 2016-06-30 was $20.00K, a 81.82% increase year-over-year.
- Theriva Biologics, Inc. depreciation for the quarter ending 2016-03-31 was $37.00K, a 362.50% increase year-over-year.
- Theriva Biologics, Inc. depreciation for the quarter ending 2015-09-30 was $20.00K, a 233.33% increase year-over-year.
- Theriva Biologics, Inc. depreciation for fiscal 2014 was $20.00K, a 53.49% decline from fiscal 2013.
- Theriva Biologics, Inc. depreciation for fiscal 2013 was $43.00K, a 31.75% decline from fiscal 2012.
- Theriva Biologics, Inc. depreciation for fiscal 2012 was $63.00K, a 56.25% decline from fiscal 2011.
- Theriva Biologics, Inc. depreciation for fiscal 2011 was $144.00K, a 58.38% decline from fiscal 2010.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 9 month as first filed | Depreciation 12 month |
|---|---|---|---|---|---|---|
| 2016-09-30 | $54.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $74.00K derived: sum of 2 quarters · filed 2016-11-01 | $111.00K 10-Q · filed 2016-11-01 | |||
| 2016-06-30 | $20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $57.00K 10-Q · filed 2016-08-03 | ||||
| 2016-03-31 | $37.00K 10-Q · filed 2016-05-05 | |||||
| 2015-09-30 | $20.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $31.00K derived: sum of 2 quarters · filed 2016-11-01 | $39.00K 10-Q · filed 2016-11-01 | $46.00K derived: sum of 4 quarters · filed 2016-11-01 | ||
| 2015-06-30 | $11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $19.00K 10-Q · filed 2016-08-03 | $26.00K derived: sum of 3 quarters · filed 2016-08-03 | $32.00K derived: sum of 4 quarters · filed 2016-08-03 | ||
| 2015-03-31 | $8.00K 10-Q · filed 2016-05-05 | $15.00K derived: sum of 2 quarters · filed 2016-05-05 | $21.00K derived: sum of 3 quarters · filed 2016-05-05 | $25.00K derived: sum of 4 quarters · filed 2016-05-05 | ||
| 2014-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $13.00K derived: sum of 2 quarters · filed 2015-11-05 | $17.00K derived: sum of 3 quarters · filed 2015-11-05 | $20.00K 10-K · filed 2015-03-16 | ||
| 2014-09-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $10.00K derived: sum of 2 quarters · filed 2015-11-05 | $13.00K 10-Q · filed 2015-11-05 | $23.00K derived: sum of 4 quarters · filed 2015-11-05 | ||
| 2014-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $7.00K 10-Q · filed 2015-08-10 | $17.00K derived: sum of 3 quarters · filed 2015-08-10 | $27.00K derived: sum of 4 quarters · filed 2015-08-10 | ||
| 2014-03-31 | $3.00K 10-Q · filed 2015-05-11 | $13.00K derived: sum of 2 quarters · filed 2015-05-11 | $23.00K derived: sum of 3 quarters · filed 2015-05-11 | $35.00K derived: sum of 4 quarters · filed 2015-05-11 | ||
| 2013-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $20.00K derived: sum of 2 quarters · filed 2015-03-16 | $32.00K derived: sum of 3 quarters · filed 2015-03-16 | $43.00K 10-K · filed 2015-03-16 | ||
| 2013-09-30 | $10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $22.00K derived: sum of 2 quarters · filed 2014-11-14 | $33.00K 10-Q · filed 2014-11-14 | $45.00K derived: sum of 4 quarters · filed 2015-03-16 | ||
| 2013-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $23.00K 10-Q · filed 2014-08-14 | $35.00K derived: sum of 3 quarters · filed 2015-03-16 | $47.00K derived: sum of 4 quarters · filed 2015-03-16 | ||
| 2013-03-31 | $11.00K 10-Q · filed 2014-05-15 | $23.00K derived: sum of 2 quarters · filed 2015-03-16 | $35.00K derived: sum of 3 quarters · filed 2015-03-16 | $54.00K derived: sum of 4 quarters · filed 2015-03-16 | ||
| 2012-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $24.00K derived: sum of 2 quarters · filed 2015-03-16 | $43.00K derived: sum of 3 quarters · filed 2015-03-16 | $63.00K 10-K · filed 2015-03-16 | ||
| 2012-09-30 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $31.00K derived: sum of 2 quarters · filed 2013-11-14 | $51.00K 10-Q · filed 2013-11-14 | $62.00K derived: sum of 4 quarters · filed 2013-11-14 | ||
| 2012-06-30 | $19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $39.00K 10-Q · filed 2013-08-14 | $50.00K derived: sum of 3 quarters · filed 2013-08-14 | $82.00K derived: sum of 4 quarters · filed 2013-08-14 | ||
| 2012-03-31 | $20.00K 10-Q · filed 2013-05-15 | $31.00K derived: sum of 2 quarters · filed 2013-05-15 | $63.00K derived: sum of 3 quarters · filed 2013-05-15 | $84.00K derived: sum of 4 quarters · filed 2013-05-15 | ||
| 2011-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-16 | $43.00K derived: sum of 2 quarters · filed 2013-04-16 | $64.00K derived: sum of 3 quarters · filed 2013-04-16 | $144.00K 10-K · filed 2013-04-16 | ||
| 2011-09-30 | $32.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14 | $53.00K derived: sum of 2 quarters · filed 2012-11-14 | $133.00K 10-Q · filed 2012-11-14 | $132.79K 10-Q · filed 2011-11-14 | $207.92K derived: sum of 4 quarters · filed 2012-11-14 | |
| 2011-06-30 | $21.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-11 | $101.00K 10-Q/A · filed 2012-09-11 | $108.11K 10-Q · filed 2011-08-15 | $175.92K derived: sum of 3 quarters · filed 2012-09-11 | $266.92K derived: sum of 4 quarters · filed 2012-09-11 | |
| 2011-03-31 | $80.00K 10-Q · filed 2012-05-15 | $154.92K derived: sum of 2 quarters · filed 2012-05-15 | $245.92K derived: sum of 3 quarters · filed 2012-05-15 | |||
| 2010-12-31 | $74.92K derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-05-11 | $165.92K derived: sum of 2 quarters · filed 2012-05-11 | $346.00K 10-K/A · filed 2012-05-11 | |||
| 2010-09-30 | $91.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $271.08K 10-Q · filed 2011-11-14 | ||||
| 2010-06-30 | $180.08K 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |